Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis - Wikidata - wikimedia - TriplyDB

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

http://www.wikidata.org/entity/Q28298164

about

Neuromyelitis optica pathogenesis and aquaporin 4 Cyclophosphamide therapy in pediatric multiple sclerosis Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate Genome-wide association study of severity in multiple sclerosis.An ImmunoChip study of multiple sclerosis risk in African Americans.Review of intervention studies on depression in persons with multiple sclerosis.Multiple sclerosis in First Nations Canadians: A pilot comparison study.Differential diagnosis of neuromyelitis optica spectrum disorders.Multiple sclerosis susceptibility alleles in African Americans.Refining the association of MHC with multiple sclerosis in African Americans.Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records.MRI correlates of disability in African-Americans with multiple sclerosis.Aggressive multiple sclerosis: proposed definition and treatment algorithm.Vitamin D in African Americans with multiple sclerosis.Progression, symptoms and psychosocial concerns among those severely affected by multiple sclerosis: a mixed-methods cross-sectional study of Black Caribbean and White British people.Retinal damage and vision loss in African American multiple sclerosis patients Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans.Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.Response to interferon-Beta treatment in afro-caribbeans with multiple sclerosis.New insights into neuromyelitis optica Exploring meanings of illness causation among those severely affected by multiple sclerosis: a comparative qualitative study of Black Caribbean and White British people.Immune mediated diseases and immune modulation in the neurocritical care unit Genetic determinants of risk and progression in multiple sclerosis.Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)The immunogenetics of multiple sclerosis: A comprehensive review.African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.Bioinformatics for study of autoimmunity.Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review.A three-dimensional approach for understanding the spectrum of idiopathic inflammatory demyelinating disorders: importance of the 'attack-related severity' axis.Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.Genetic risk variants in African Americans with multiple sclerosis Demyelinating events in early multiple sclerosis have inherent severity and recovery.The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.Clinical predictors of early second event in patients with clinically isolated syndrome.Spinal cord lesions and disability in Hispanics with multiple sclerosis.Modeling disease severity in multiple sclerosis using electronic health records Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis.

P2860

Q21245240-6F4E9551-7D29-4B6F-B851-2C1BEAB5936B Q24630626-440FFB7E-31CA-40AA-B80B-00D0E723F8D2 Q28276365-9159D13D-2B7C-4D7B-A516-46F459BA93A9 Q29417054-74360A20-8CF7-40ED-889F-5D63C352087C Q30300285-3BF91FD2-CDB1-42B9-A1B0-6F0AE0575FD8 Q30542657-F7CF37D6-B827-4A89-B1B8-71A11C827AA2 Q33692742-B2A9ED52-3FCA-4462-B4DE-CA2A8BF24A4F Q33812063-B122F21F-0F30-48EC-97F1-3BD961EF297C Q33892035-F190A46F-8BDA-4390-A5B7-BE1B1C00C14A Q33980298-B7E5ED2A-C7BC-4C3A-9FD3-3EE5C15DD4A7 Q34185496-2E86083E-2ED2-4E28-B377-36BFFF9CC27E Q34382763-5006E13D-21D4-4C65-94F1-503DAF0AA568 Q34478828-BE549B49-329A-4604-92DE-041441CAC658 Q34999315-8C3CEA7C-B9D1-4F17-84C2-E8E33F11720F Q35009113-B1F3F554-F5C5-4425-819C-39BEDDAF0B46 Q35044471-A0FCF32C-EAB7-410B-8AC2-D33AFCC03C49 Q35101408-C14C9DCF-199D-460C-AF23-C9D7FC54D67F Q35116360-0F8C9B01-6CE8-4CA7-8048-3B94CD3048A9 Q35137159-D8A362CE-2F08-4827-8A4A-256663887292 Q35367901-1C3E0580-3A23-4959-998B-3AF3022058A7 Q35539641-9548FAA7-0E7F-4D51-8488-B340110DA871 Q35618673-193D71AA-1832-4C3F-B2DA-CD1BE13F3A8E Q35729575-98C86F06-057B-48C3-97DA-4D3AEBB136F7 Q35915818-9F623A45-BB69-4379-A9A4-D5B91A65AE7A Q35941630-E88F03CD-AEC4-4203-92C2-B45BB6D0D5BD Q36077974-40B88FBC-03A1-4567-9C94-887E985EB7FF Q36394834-F553952E-668B-4D4F-84DD-390BDE787B3B Q36440208-38E29FA5-D606-47F2-B4A3-DEE90FC8FA0B Q36687906-254AC5A3-D96B-4AFA-84D7-FC15596D2ED9 Q36722180-436EAF85-054F-4320-8288-C08FF5AC7C69 Q36794109-E55DD6B3-4682-44C0-BF75-AABC63C7E394 Q37072366-51CDCA6E-2F49-49C8-825C-7E93403B2770 Q37108829-5C34D363-52D5-4659-9569-707052E0931E Q37163271-48FA5C5F-88EE-499B-8BF2-B8B30AD9146C Q37180615-A58E8875-2E7F-4BE3-B57E-58DA9E3905EF Q37187340-5F0B2908-2E6A-4D21-89DD-85C75F844160 Q37255947-D7FD8E2D-5A29-4300-AD89-3F60FE9C2E75 Q37275133-9975EFC1-5AAE-4C97-922E-79058859B39F Q37297607-4255FC47-A787-449E-9977-A72769373B32 Q37343648-A4AFC8CB-2FF6-4E20-936C-4E4CD02B35E4

P2860

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

http://www.wikidata.org/entity/Q28298164

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Clinical characteristics of Af ...... ricans with multiple sclerosis

@ast

Clinical characteristics of Af ...... ricans with multiple sclerosis

@en

Clinical characteristics of Af ...... ricans with multiple sclerosis

@nl

type

label

Clinical characteristics of Af ...... ricans with multiple sclerosis

@ast

Clinical characteristics of Af ...... ricans with multiple sclerosis

@en

Clinical characteristics of Af ...... ricans with multiple sclerosis

@nl

prefLabel

Clinical characteristics of Af ...... ricans with multiple sclerosis

@ast

Clinical characteristics of Af ...... ricans with multiple sclerosis

@en

Clinical characteristics of Af ...... ricans with multiple sclerosis

@nl

P1433

Q28298164-D2D73917-6F17-47FE-BF46-50356626B071

P1476

Q28298164-319DF37C-6F8D-406D-812B-4A3F3A273544

P2093

Q28298164-0A2F7692-5798-43B4-B44F-9832954DC4E3

Q28298164-35A28D62-D924-49ED-9398-27008A4BB6B3

Q28298164-397A142B-0FBB-4D50-AABD-AC6F14F556BB

Q28298164-3ECD4D0A-F921-48F5-98AF-1CA0A89A10F9

Q28298164-48A6F0A3-4C59-4E90-9D18-36FD3A48934D

Q28298164-4B5A78F4-B147-4820-ABCC-058ABAA1D60D

Q28298164-5FD5FADF-F1F6-40C2-9F36-56F03FE613CA

Q28298164-88A9945F-121C-4106-A684-D320B156B5CE

Q28298164-90E8289A-B8ED-42AB-BF0E-D22875EAF926

Q28298164-95FF1370-643B-4800-B095-EF946DDF6C10

P304

Q28298164-9A0CA5EF-D453-4BB5-BCF6-18AE045FD1E9

P31

Q28298164-5D048DC1-ECA9-484B-B2E0-40E3392CFE44

P3181

Q28298164-D8FA64C1-F5A6-4205-8C2D-702A6A80250A

P356

Q28298164-75D7B570-4D63-4205-8B32-9A17841C56A4

P407

Q28298164-8C83BB75-EA8D-4AF5-969C-0E25E9D5C637

P433

Q28298164-A6E70E85-70CB-4B0F-99A1-53A206BE941F

P478

Q28298164-8A03761E-C766-4696-BB08-C38B014EBE76

P50

Q28298164-BF2A923A-4748-464F-ACCD-C51F15E29471

P577

Q28298164-9519DBDD-C0F2-4EC0-8E03-E8640C076555

P698

Q28298164-1FB81536-7972-41AD-B7F3-869D36D70228

P921

Q28298164-334BC98A-5943-447C-B8B0-B19E331307BA

P3181

P356

01.WNL.0000145762.60562.5D

P1433

P1476

Clinical characteristics of Af ...... ricans with multiple sclerosis

@en

P2093

B A C Cree

http://www.w3.org/2001/XMLSchema#string

B Weinstock-Guttman

http://www.w3.org/2001/XMLSchema#string

C DeLoa

http://www.w3.org/2001/XMLSchema#string

D Bourdette

http://www.w3.org/2001/XMLSchema#string

D Glidden

http://www.w3.org/2001/XMLSchema#string

D Reich

http://www.w3.org/2001/XMLSchema#string

D S Goodin

http://www.w3.org/2001/XMLSchema#string

J A Cohen

http://www.w3.org/2001/XMLSchema#string

J R Oksenberg

http://www.w3.org/2001/XMLSchema#string

M Pericak-Vance

http://www.w3.org/2001/XMLSchema#string

P304

2039-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

74494

http://www.w3.org/2001/XMLSchema#string

P356

10.1212/01.WNL.0000145762.60562.5D

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan L Haines

P577

2004-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15596747

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis